High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris

Patent metadata

Field	Value
Publication number	US-11214610-B2
Application number	US-201213466795-A
Country	US
Kind code	B2
Filing date	May 8, 2012
Priority date	Dec 1, 2010
Publication date	Jan 4, 2022
Grant date	Jan 4, 2022

Abstract

Methods for producing heterologous multi-subunit proteins in transformed cells are disclosed. In particular, the present disclosure provides improved methods of producing multi-subunit proteins, including antibodies and other multi-subunit proteins, which may or may not be secreted, with a higher yield and decreased production of undesired side-products. In exemplary embodiments, the transformed cells are a yeast, e.g., methylotrophic yeast such as Pichia pastoris.

First claim

The invention claimed is:

1. A fermentation method for the production and recovery of full-length antibodies from a Pichia pastoris culture, comprising:
(a) providing a culture medium comprising at least one fermentable carbon source and further comprising Pichia pastoris yeast cells comprising genes that provide for the expression and secretion of the subunits of said antibody and culturing said yeast cells for a time sufficient to permit the growth of the yeast cells until the at least one carbon source in the culture is consumed, wherein said genes are under control of a constitutive promoter and wherein said consumption is evidenced by a sudden spike in the dissolved oxygen in the culture (“growth phase”);
(b) immediately after the at least one carbon source is consumed adding ethanol to said carbon source-depleted culture medium, wherein said ethanol addition consists of a single bolus of ethanol being added to said carbon-source depleted Pichia pastoris culture, which ethanol addition results in the concentration of ethanol in the culture ranging from between about 0.5% (w/v) and about 1.5% (w/v), and allowing said culture to equilibrate for a period of time (“equilibration phase”);
(c) after said equilibration phase (b) culturing said Pichia pastoris culture by adding a feed comprising a carbon source to said culture, wherein the ethanol concentration in the culture is maintained between about 0.5% (w/v) and about 1.5% (w/v) by adjusting the feed rate and wherein said feed comprising a carbon source does not comprise ethanol and culturing said yeast such that said yeast cells produce and secrete said antibody into the culture medium (“production phase”), and
(d) recovering said antibody from said culture medium, wherein said full length antibody comprises a human IgG constant region; and
(e) detecting product-associated variants;
wherein said method decreases the relative abundance of antibody complexes having aberrant stoichiometry relative to the same method effected in the absence of the single bolus addition of ethanol.

2. The method of claim 1 , wherein the ethanol bolus further enhances the formation of stable disulfide bonds relative to the same method effected in the absence of the bolus of ethanol.

3. The method of claim 1 , wherein said IgG constant region comprises a human IgG1 constant region.

4. The method of claim 1 , wherein said antibody comprises a human antibody or a humanized antibody.

5. The method of claim 1 , which decreases the relative abundance of one or more product-associated variants having aberrant stoichiometry selected from the group consisting of a half-antibody product-associated variant containing one antibody heavy chain and one antibody light chain (“H1L1”), a product-associated variant containing two antibody heavy chains and one antibody light chain (“H2L1”), and an antibody dimer containing four antibody heavy chains and four antibody light chains (“H4L4”) product-associated variants relative to the same method effected in the absence of the bolus of ethanol.

6. The method of claim 5 , wherein said product-associated variants comprise the half-antibody product-associated variant containing one antibody heavy chain and one antibody light chain (“H1L1”) product-associated variant.

7. The method of claim 1 , wherein step (b) results in a concentration of ethanol in said culture of about 1% (w/v).

8. The method of claim 1 , wherein step (c) comprises providing oxygen to said cells.

9. The method of claim 1 wherein the time between step (a) and step (b) is less than about 72 hours, less than about 48 hours, less than about 24 hours, less than about 12 hours, less than about 9 hours, less than about 6 hours, less than about 5 hours, less than about 4 hours, less than about 3 hours, less than about 90 minutes, less than about 30 minutes, less than about 5 minutes, or less than about 1 minute.

10. The method of claim 1 , wherein the time between step (b) and step (c) is less than about 10 hours, less than about 9 hours, less than about 8 hours, less than about 7 hours, less than about 6 hours, less than about 5 hours, less than about 4 hours, less than about 3 hours, less than about 2 hours, less than about 90 minutes, less than about 80 minutes, less than about 70 minutes, less than about 60 minutes, less than about 50 minutes, less than about 40 minutes, less than about 30 minutes, less than about 20 minutes, less than about 10 minutes, less than about 5 minutes, or less than about 1 minute.

11. The method of claim 1 , wherein the Pichia pastoris yeast cells comprise genes that provide for expression of said antibody integrated into one or more genomic loci of said Pichia pastoris yeast cells.

12. The method of claim 1 , wherein step (c) comprises adding a feed comprising a carbon source to said culture 30 minutes or less after adding the ethanol in step (b).

13. The method of claim 1 , wherein detecting said product-associated variants comprises detecting said product associated variants by size exclusion chromatography.

14. The method of claim 1 , wherein detecting said product-associated variants comprises detecting said product associated variants by gel electrophoresis.

15. The method of claim 1 , wherein in step (b) the ethanol addition results in the concentration of ethanol in the culture ranging from between about 0.8% (w/v) and about 1.25% (w/v).

16. The method of claim 1 , wherein in step (b) the ethanol addition results in the concentration of ethanol in the culture ranging from between about 0.8% (w/v) and about 1.25% (w/v), and wherein in step (c) the ethanol concentration in the culture is maintained between about 0.8% (w/v) and about 1.25% (w/v) by adjusting the feed rate.

17. The method of claim 1 , wherein in step (b) the ethanol addition results in the concentration of ethanol in the culture of about 1% (w/v), and wherein in step (c) the ethanol concentration in the culture is maintained at about 1% (w/v).

18. The method of claim 17 , wherein said Pichia pastoris yeast cells comprise multiple copies of the heavy chain gene and multiple copies of the light chain gene, wherein the heavy chain gene copy number is different from the light chain gene copy number.

19. The method of claim 17 , wherein said Pichia pastoris yeast cells comprise four copies of the heavy chain gene and three copies of the light chain gene.

Assignees

• Mcneill Patricia Dianne
• Garcia Martinez Leon F
• Janson Nicole
• Lesnicki Gary
• Qi Pei
• Latham John A
• H Lundbeck As

Inventors

• Mcneill Patricia Dianne
• Garcia-Martinez Leon F
• Janson Nicole
• Lesnicki Gary
• Qi Pei
• Latham John A

Classifications

• C12N15/81 Primary

  for yeasts · CPC title

• C12P21/00

  Preparation of peptides or proteins (single cell protein C12N1/00) · CPC title

• C12N15/67

  General methods for enhancing the expression · CPC title

• C07K16/00 Primary

  Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title

• C07K2317/14

  Specific host cells or culture conditions, e.g. components, pH or temperature · CPC title